These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6129644)

  • 21. Cimetidine does not change the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Life Sci; 1991; 49(16):1163-8. PubMed ID: 1680211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIF-I's differential actions as an opiate antagonist.
    Kastin AJ; Olson RD; Ehrensing RH; Berzas MC; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1979 Dec; 11(6):721-3. PubMed ID: 43981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of melanostatin (MIF-1) in mice.
    Brus R; Szkilnik R; Stanosek B; Makowska B; PiguĊ‚a J
    Acta Physiol Pol; 1984; 35(5-6):447-53. PubMed ID: 6152791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of melanotrophin release inhibiting factor (MIF) and cyclo (Leu-Gly) on the tolerance to morphine-induced antinociception in the rat: a dose-response study.
    Bhargava HN
    Br J Pharmacol; 1981 Apr; 72(4):707-14. PubMed ID: 6116510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of prolyl-leucyl-glycinamide to alter analgesia measured by the Takemori test in morphine-pretreated rats.
    Mucha RF; Kalant H
    J Pharm Pharmacol; 1979 Aug; 31(8):572-3. PubMed ID: 40008
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia.
    Kavaliers M; Innes DG
    Peptides; 1993; 14(5):1001-4. PubMed ID: 7904339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the oxytocin fragment prolyl-leucyl-glycinamide on sexual behavior in the rat.
    Gorzalka BB; Luck KA; Tanco SA
    Pharmacol Biochem Behav; 1991 Feb; 38(2):273-9. PubMed ID: 1676168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential activity of the endogenous antiopiate Tyr-MIF-1 after various intensities of stress.
    Galina ZH; Kastin AJ
    Neurosci Lett; 1988 Feb; 84(3):312-6. PubMed ID: 2895440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolyl-leucyl-glycinamide (PLG): inhibition of offensive aggression in mice.
    Kavaliers M; Hirst M
    Life Sci; 1986 Nov; 39(19):1729-35. PubMed ID: 2877382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesia and the blood-brain barrier transport system for Tyr-MIF-1/enkephalins: evidence for a dissociation.
    Banks WA; Kastin AJ; Nager BJ
    Neuropharmacology; 1988 Feb; 27(2):175-9. PubMed ID: 2895431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Life Sci; 1984 Jun; 34(26):2559-66. PubMed ID: 6146083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naloxone blockade of morphine analgesia: a dose-effect study of duration and magnitude.
    Markowitz R; Jacobson J; Bain G; Kornetsky C
    J Pharmacol Exp Ther; 1976 Nov; 199(2):385-8. PubMed ID: 978492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiopioid properties of the TYR-MIF-1 family.
    Bocheva A; Dzambazova-Maximova E
    Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):673-7. PubMed ID: 15632952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIF-I suppresses deprivation-induced fluid consumption in rats.
    Olson RD; Kastin AJ; Olson GA; King BM; Von Almen TK; Berzas MC; Ibanez ML; Coy DH
    Peptides; 1980; 1(4):353-7. PubMed ID: 6117840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain peptide reverses effect of morphine on human lymphocytes.
    Strimas JH; Chi DS; Kastin AJ
    Peptides; 1987; 8(6):1165-7. PubMed ID: 2894648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Picrotoxin-induced seizures modified by morphine and opiate antagonists.
    Thomas J; Nores WL; Kenigs V; Olson GA; Olson RD
    Pharmacol Biochem Behav; 1993 Jul; 45(3):615-7. PubMed ID: 8101378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.